Fertility preserving surgical treatment of ovarian borderline tumour: long-term consequence for fertility and recurrence

References

• Taylor HC. Malignant and semi-malignant tumors of the ovary. Surg Gynecol Obstet. 1929; 48: 204–30
   Google Scholar
• Barakat RR. Borderline tumors of the ovary. Obstet Gynecol Clin North Am. 1994; 21: 93–105
   PubMed Web of Science ®Google Scholar
• Trope CG, et al. Surgery for borderline tumor of the ovary. Semin Surg Oncol. 2000; 19: 69–75
   PubMedGoogle Scholar
• Auranen A, et al. Borderline ovarian tumors in Finland: epidemiology and familial occurrence. Am J Epidemiol. 1996; 144: 548–53
   PubMed Web of Science ®Google Scholar
• Rice LW, et al. Epithelial ovarian tumors of borderline malignancy. Gynecol Oncol. 1990; 39(2)195–8
   PubMed Web of Science ®Google Scholar
• Tazelaar HD, et al. Conservative treatment of borderline ovarian tumors. Obstet Gynecol. 1985; 66: 417–22
   PubMed Web of Science ®Google Scholar
• Seidman JD, Kurman RJ. Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators. Hum Pathol. 2000; 31: 539–57
   PubMed Web of Science ®Google Scholar
• Whittemore AS, et al. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. IV. The pathogenesis of epithelial ovarian cancer. Collaborative Ovarian Cancer Group. Am J Epidemiol. 1992; 136: 1212–20
   PubMed Web of Science ®Google Scholar
• Harris R, et al. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. III. Epithelial tumors of low malignant potential in white women. Collaborative Ovarian Cancer Group. Am J Epidemiol. 1992; 136: 1204–11
   PubMed Web of Science ®Google Scholar
• Riman T, et al. Risk factors for epithelial borderline ovarian tumors: results of a Swedish case-control study. Gynecol Oncol. 2001; 83: 575–85
   PubMed Web of Science ®Google Scholar
• Gotlieb WH, ; National Israel Ovarian Cancer Study Group, et al. Demographic and genetic characteristics of patients with borderline ovarian tumors as compared to early stage invasive ovarian cancer. Gynecol Oncol. 2005;97:780–3.
   PubMed Web of Science ®Google Scholar
• FIGO Committee on Gynecologic Oncology. Staging classifications and clinical practice guidelines of gynaecologic cancers. Int J Gynecol Obstet. 2000;70:207–312; Published in September 2000 by Elsevier.
   PubMed Web of Science ®Google Scholar
• Kennedy AW, Hart WR. Ovarian papillary serous tumors of low malignant potential (serous borderline tumors). A long-term follow-up study, including patients with microinvasion, lymph node metastasis, and transformation to invasive serous carcinoma. Cancer. 1996; 78: 278–86
   PubMed Web of Science ®Google Scholar
• Seracchioli R, et al. Fertility and tumor recurrence rate after conservative laparoscopic management of young women with early-stage borderline ovarian tumors. Fertil Steril. 2001; 76: 999–1004
   PubMed Web of Science ®Google Scholar
• Fauvet R, , et al. Fertility after conservative treatment for borderline ovarian tumors: a French multicenter study. Fertil Steril. 2005;83:284–90; quiz 525–6.
   PubMed Web of Science ®Google Scholar
• Tinelli R, et al. Conservative surgery for borderline ovarian tumors: A review. Gynecol Oncol. 2006; 100: 185–91
   PubMed Web of Science ®Google Scholar
• Beiner ME, et al. Infertility treatment after conservative management of borderline ovarian tumors. Cancer. 2001; 92: 320–5
   PubMed Web of Science ®Google Scholar
• International Federation of Gynecology and Obstetrics Cancer Committee. Staging announcement. Gynecol Oncol. 1986;25:383.
   Google Scholar
• Barnhill DR, et al. Preliminary analysis of the behavior of stage I ovarian serous tumors of low malignant potential: a Gynecologic Oncology Group study. J Clin Oncol. 1995; 13: 2752–6
   PubMed Web of Science ®Google Scholar
• Camatte S, et al. Clinical outcome after laparoscopic pure management of borderline ovarian tumors: results of a series of 34 patients. Ann Oncol. 2004; 15: 605–9
   PubMed Web of Science ®Google Scholar
• Camatte S, et al. Fertility results after conservative treatment of advanced stage serous borderline tumour of the ovary. BJOG. 2002; 109: 376–80
   PubMed Web of Science ®Google Scholar
• Gotlieb WH, et al. Borderline tumors of the ovary: fertility treatment, conservative management, and pregnancy outcome. Cancer. 1998; 82: 141–6
   PubMed Web of Science ®Google Scholar
• Brinton LA, , et al Ovulation induction and cancer risk. Fertil Steril. 2005;83:261–74; quiz 525–6.
   PubMed Web of Science ®Google Scholar
• Glud E, et al. Fertility drugs and ovarian cancer. Epidemiol Rev. 1998; 20: 237–57
   PubMed Web of Science ®Google Scholar
• Fasouliotis SJ. Safety and efficacy of infertility treatment after conservative management of borderline ovarian tumors: a preliminary report. Fertil Steril. 2004; 82: 568–72
   PubMed Web of Science ®Google Scholar
• Darai E, et al. Management and outcome of borderline ovarian tumors incidentally discovered at or after laparoscopy. Acta Obstet Gynecol Scand. 1998; 77: 451–7
   PubMed Web of Science ®Google Scholar
• Trimble CL, Trimble EL. Ovarian tumors of low malignant potential Oncology (Williston Park). 2003;17:1563–7; discussion 1567–70, 1575.
   PubMedGoogle Scholar